Institute of Pharmaceutical Research, GLA University, Mathura, 281406, India.
Curr Pharm Biotechnol. 2022;23(2):235-260. doi: 10.2174/1389201022666210322124348.
The world population has suffered as a result of the COVID-19 pandemic. The disease has become life-threatening in a very short time, harming citizens and the economic systems globally. The novel virus SARS-CoV-2 has been known as the causative agent of COVID-19. The SARS-CoV-2 is a single-stranded RNA virus having ~30 kb genomic components, which are 70% identical to SARS-CoV. The main process of the pathophysiology of COVID-19 has been associated with the interaction of a novel coronavirus with host cell receptor, angiotensin-converting enzyme-2 (ACE 2), by fusion. Therapeutic agents having serine protease inhibitors and ACE-2 blockers may be explored for the treatment by inhibiting the viral target such as Mpro, RdRp, PLpro, and helicase. Herbal medicine has a wide array of chemical entities with potential health benefits, including antiviral activity, which may be explored as an alternative treatment for COVID-19. The herbal bioactives like catechins, andrographolide, hesperidin, biorobin, scutellarein, silvestrol, shikonin, tryptanthrin, vitexin quercetin, myricetin, caffeic acid, psoralidin, luteolin, etc. have shown potential inhibitory effect against SARS-CoV-2. Recent research reports indicate that the various plant secondary metabolites have shown potential antiviral activities. The present review article highlights the recent information on the mechanism of actions and applications of herbal medicine in the treatment of COVID-19.
世界人口因 COVID-19 大流行而遭受苦难。这种疾病在很短的时间内就变得危及生命,对全球公民和经济系统造成伤害。新型病毒 SARS-CoV-2 被认为是 COVID-19 的病原体。SARS-CoV-2 是一种单链 RNA 病毒,具有约 30 kb 的基因组成分,与 SARS-CoV 有 70%的同源性。COVID-19 的病理生理学的主要过程一直与新型冠状病毒与宿主细胞受体血管紧张素转换酶 2(ACE 2)通过融合相互作用有关。具有丝氨酸蛋白酶抑制剂和 ACE-2 阻滞剂的治疗剂可能通过抑制病毒靶标(如 Mpro、RdRp、PLpro 和 helicase)来探索治疗方法。草药具有广泛的化学实体,具有潜在的健康益处,包括抗病毒活性,可作为 COVID-19 的替代治疗方法进行探索。草药生物活性物质,如儿茶素、穿心莲内酯、橙皮苷、熊果酸、黄芩素、雪上一枝蒿素、紫草素、色满醇、补骨脂素、木犀草素、槲皮素、杨梅素、咖啡酸、补骨脂定、木樨草素等,已显示出对 SARS-CoV-2 的潜在抑制作用。最近的研究报告表明,各种植物次生代谢产物具有潜在的抗病毒活性。本文综述了草药在治疗 COVID-19 中的作用机制和应用的最新信息。